Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma by Sana’ Hidmi, Hovav Nechushtan, Ehud Razin, Sagi Tshori

Get full text

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients by Adi Horesh, Rena Pollack, Rena Pollack, Hovav Nechushtan, Hovav Nechushtan, Rivka Dresner-Pollak, Rivka Dresner-Pollak, Tzahi Neuman, Tzahi Neuman

Get full text

The functional role of Nudt2 in human triple negative breast cancer by Rasha Abu-Rahmah, Rasha Abu-Rahmah, Hovav Nechushtan, Sanaa Hidmi, Amichay Meirovitz, Ehud Razin, Tamar Peretz

Get full text

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report by Johnathan Arnon, MD, Anna Elia, MD, Yuval Nevo, PhD, Alexander Lossos, MD, Hovav Nechushtan, MD, PhD

Get full text

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events by Michal Lotem, Limor Rubin, Aviv Talmon, Yaarit Ribak, David Lavie, Hovav Nechushtan, Nadia Caplan, Oded Shamriz, Irit Adini, Yuval Tal

Get full text

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing by Or Sehayek, Waleed Kian, Amir Onn, Ronen Stoff, Hadas Gantz Sorotsky, Melanie Zemel, Jair Bar, Yulia Dudnik, Hovav Nechushtan, Yakir Rottenberg, Lior Soussan-Gutman, Addie Dvir, Laila C. Roisman, Nir Peled

Get full text

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world da... by Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, Anastasiya Lobachov, Rinat Mandelboim, Tzippy Shochat, Damien Urban, Mira Wollner, Hovav Nechushtan, Ofer Rotem, Alona Zer, Sameh Daher, Jair Bar, On behalf of the Israel Lung Cancer Group

Get full text

Ap4A Regulates Directional Mobility and Antigen Presentation in Dendritic Cells by Shin La Shu, Lakshmi Bhargavi Paruchuru, Neil Quanwei Tay, Yen Leong Chua, Adeline Shen Yun Foo, Chris Maolin Yang, Ka Hang Liong, Esther Geok Liang Koh, Angeline Lee, Hovav Nechushtan, Ehud Razin, David Michael Kemeny

Get full text

Long term follow-up of EGFR mutated NSCLC cases by Gad Rennert, Maya Gottfried, Hedy S Rennert, Flavio Lejbkowicz, Meira Frank, Ilana Cohen, Shiri Kelt, Abed Agbarya, Elizabeta Dudnik, Julia Dudnik, Rivka Katznelson, Moshe Mishali, Natalie Maimon Rabinovich, Hovav Nechushtan, Amir Onn, Shoshana Keren Rosenberg, Mariana Wollner, Alona Zer, Jair Bar, Naomi Gronich

Get full text

Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells by Avital Granit Mizrahi, Avital Granit Mizrahi, Ahinoam Gugenheim, Haneen Hamad, Roa’a Hamed, Nino Tetro, Ofra Maimon, Salome Khutsurauli, Hovav Nechushtan, Benjamin Nisman, Deborah Duran, Deborah Duran, Widad Samman, Widad Samman, Liron Birimberg-Schwartz, Liron Birimberg-Schwartz, Liron Birimberg-Schwartz, Myriam Grunewald, Myriam Grunewald, Sara Eyal, Tamar Peretz, Tamar Peretz

Get full text

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy by Shay Golan, Vered Bar, Seth J. Salpeter, Guy Neev, German Creiderman, Daniel Kedar, Sara Aharon, Lubov Turovsky, Adi Zundelevich, Hamutal Shahar, Hagit Shapira, Giuseppe Mallel, Erez Stossel, Nancy Gavert, Ravid Straussman, Zohar Dotan, Raanan Berger, Chani Stossel, Talia Golan, Sharon Halperin, Dan Leibovici, Shani Breuer, Yakir Rottenberg, Liat Applebaum, Ayala Hubert, Hovav Nechushtan, Tamar Peretz, Aviad Zick, Boris Chertin, Dmitry Koulikov, Amir Sonnenblick, Amir Sonnenblick, Eli Rosenbaum

Get full text